We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Peptide-Based Wound Dressing Kills Bacteria Efficiently

By HospiMedica International staff writers
Posted on 19 Aug 2020
An advanced wound dressing that contains cellulose membranes with bifunctional peptides shows potent antimicrobial activity, according to a new study.

Developed at the Swiss Federal Laboratories for Materials Science and Technology (Empa; Dübendorf, Switzerland), the dressings, made from plant‐derived cellulose fibers with a diameter of less than one micrometer, are electrospun into a delicate multi-layered, three-dimensional (3D) fabric that also contains the polymer polyurethane. More...
The cellulose membrane contains a bifunctional peptide which combines an antimicrobial peptide (AMP) and a cellulose binding peptide (CBP), with tight control over peptide concentrations.

The fiber scaffold of the fibroblast cytocompatible membranes are saturated with such bifunctional peptides, affecting bacteria via multiple modes of action, reducing evolutionary pressure selecting for antibiotic resistance. In cell cultures, the dressing exhibited a log4 reduction against Staphylococcus aureus, and a log1 reduction against Pseudomonas aeruginosa. In addition, using the cell adhesive CBP induced a 2.2‐fold increase in cell spreading, compared to pristine cellulose. The study was published in the July 2020 issue of Advanced Healthcare Materials.

“In bacterial cultures, over 99.99% of the germs were killed by the peptide-containing membranes. In future, the antimicrobial membranes will be equipped with additional functions,” said co-senior author Katharina Maniura-Weber, PhD, of the Empa Biointerfaces lab. “The peptides might, for instance, be functionalized with binding sites that enable the controlled release of further therapeutic substances.”

AMPs are potent, broad spectrum therapeutic agents that have been shown to kill both Gram positive and gram negative bacteria, enveloped viruses, fungi, and even some cancerous cells. Unlike antibiotic drugs, AMPs appears to destabilize biological membranes, can form transmembrane channels, and may have the ability to function as immunomodulators by altering host gene expression, inducing chemokine production, promoting wound healing, and modulating the responses of dendritic cells and cells of the adaptive immune response.

Related Links:

Swiss Federal Laboratories for Materials Science and Technology


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.